SPECIAL FONTS

Brand Owner (click to sort) Address Description
ADOMET Gnosis S.p.A. Piazza Filippo Meda 3 MILANO 20121 Italy Figurative trademark consisting in the word ADOMET in special fonts, wherein the first letter is a capital letter; on top of the letter d there appears the representation of a pinwheel.;Dietary supplements;Color is not claimed as a feature of the mark.;
D LIFE DELIFEPHARMA Relife S.r.l. Via dei Sette Santi, 3 I-50131 Firenze Italy Figurative trademark consisting of the wording D LIFE DELIFE PHARMA in special fonts; the letter D, which size is larger than the remaining letters, appears at a central position; such letter is pink-coloured and fades towards its right side; the word LIFE appears in the inner part of the letter D; the first three letters of such word are grey-coloured whereas the last letter, which partially overlaps with the letter D, is pink-coloured; under the letter D there appears the grey-coloured wording DELIFE PHARMA, with capital first letters.;Dermatological pharmaceutical products;Cosmetics and cosmetic preparations;D LIFE DE LIFE PHARMA;The color(s) gray and pink is/are claimed as a feature of the mark.;PHARMA;
D LIFE DELIFEPHARMA DELIFE PHARMA SRL Via Abbadesse, 20 I-20124 MILANO Italy Figurative trademark consisting of the wording D LIFE DELIFE PHARMA in special fonts; the letter D, which size is larger than the remaining letters, appears at a central position; such letter is pink-coloured and fades towards its right side; the word LIFE appears in the inner part of the letter D; the first three letters of such word are grey-coloured whereas the last letter, which partially overlaps with the letter D, is pink-coloured; under the letter D there appears the grey-coloured wording DELIFE PHARMA, with capital first letters.;Dermatological pharmaceutical products;Cosmetics and cosmetic preparations;D LIFE DE LIFE PHARMA;The color(s) gray and pink is/are claimed as a feature of the mark.;PHARMA;
DIPHARMA Dipharma Francis S.r.l. Via Bissone, 5 I-20021 Baranzate (MI) Italy The mark consists of a Complex trademark consisting of the word Dipharma in special fonts, the first letter being capital. At the left side of the trademark there appears an equilateral triangle, the left side of which is perpendicular to the base of the trademark and the sides of which are the main bases of three identical trapeziums.;Color is not claimed as a feature of the mark.;Chemicals for use in the manufacture of active pharmaceutical ingredients; chemical compositions being active ingredients for use in the manufacture of various pharmaceutical preparations, namely antimycotic/antifungal preparations, antiallergic preparations, antihistaminic preparations, antiasthmatic preparations, antiacne preparations, antimigraine preparations, antimalarial/antiprotozoal preparations, antithrombotic preparations, nootropic preparations, antiglaucoma preparations, immunomodulator preparations, CNS stimulant preparations, antibacterial/antibiotic preparations, antiulcerative/gastric proton pump inhibitor preparations, ACE inhibitor preparations, antihypertensive preparations, antiParkinson/Dopamine receptor agonist preparations, antimuscarinic (anti urinary incontinence) preparations, antidepressant/serotonin noradrenaline reuptake inhibitor preparations, analgesic preparations, antipsychotic preparations, dopamine receptor antagonist preparations, sedative/hypnotic preparations and anticonvulsant preparations;
DIPHARMA Dipharma S.p.A. Via XXIV Maggio, 40 I-33036 Mereto di Tomba (UD) Italy The mark consists of a Complex trademark consisting of the word Dipharma in special fonts, the first letter being capital. At the left side of the trademark there appears an equilateral triangle, the left side of which is perpendicular to the base of the trademark and the sides of which are the main bases of three identical trapeziums.;Color is not claimed as a feature of the mark.;Chemicals for use in the manufacture of active pharmaceutical ingredients; chemical compositions being active ingredients for use in the manufacture of various pharmaceutical preparations, namely antimycotic/antifungal preparations, antiallergic preparations, antihistaminic preparations, antiasthmatic preparations, antiacne preparations, antimigraine preparations, antimalarial/antiprotozoal preparations, antithrombotic preparations, nootropic preparations, antiglaucoma preparations, immunomodulator preparations, CNS stimulant preparations, antibacterial/antibiotic preparations, antiulcerative/gastric proton pump inhibitor preparations, ACE inhibitor preparations, antihypertensive preparations, antiParkinson/Dopamine receptor agonist preparations, antimuscarinic (anti urinary incontinence) preparations, antidepressant/serotonin noradrenaline reuptake inhibitor preparations, analgesic preparations, antipsychotic preparations, dopamine receptor antagonist preparations, sedative/hypnotic preparations and anticonvulsant preparations;
RES CONCEPT Res Pharma Industriale S.r.l. Via Giacomo Leopardi, 10 Milano I-20123 Italy Figurative trademark consisting of the wording RES concept in special fonts, the first word RES being in blue capital letters, the second word concept being in pink lower case letters; in between the two words there is a fancy logo formed by three contacting half-ellipses alternately coloured in two shades of pink and embracing the first two letters of the word concept. The first part of the mark, RES, is in blue color; the second, CONCEPT, and the fantasy element that comes before it, are in two different shades of pink.;Soaps; perfumery, essential oils, cosmetics, hair lotions; dentifrices;The color(s) blue and pink is/are claimed as a feature of the mark.;Chemicals for use in the cosmetic industry;CONCEPT;
 

Where the owner name is not linked, that owner no longer owns the brand

   
Technical Examples
  1. The invention is generally directed to a method for selecting a font that uses a mark-up language document to group together multiple pre-existing fonts into a single font family or "virtual font." The mark-up language document includes rules regarding the conditions under which individual fonts within the family are to be used. This permits, for example, a font developer to create, in an efficient manner, an international font using several preexisting fonts.